Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 7 | 2025 | 112 | 1.970 |
Why?
|
| Leptin | 4 | 2016 | 218 | 0.970 |
Why?
|
| Diet, High-Fat | 7 | 2025 | 268 | 0.970 |
Why?
|
| Uterus | 3 | 2026 | 541 | 0.930 |
Why?
|
| Choristoma | 1 | 2026 | 43 | 0.930 |
Why?
|
| Genitalia, Female | 1 | 2026 | 44 | 0.910 |
Why?
|
| Receptors, Leptin | 3 | 2022 | 40 | 0.880 |
Why?
|
| Sugars | 2 | 2022 | 17 | 0.840 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2020 | 237 | 0.830 |
Why?
|
| Insulins | 1 | 2022 | 18 | 0.750 |
Why?
|
| Lipid Metabolism | 3 | 2020 | 387 | 0.740 |
Why?
|
| Placenta | 5 | 2022 | 504 | 0.710 |
Why?
|
| Endometriosis | 1 | 2024 | 176 | 0.670 |
Why?
|
| Endometrium | 1 | 2024 | 292 | 0.660 |
Why?
|
| Insulin Resistance | 3 | 2025 | 690 | 0.650 |
Why?
|
| Dietary Sucrose | 2 | 2018 | 40 | 0.630 |
Why?
|
| Fetal Development | 3 | 2020 | 121 | 0.630 |
Why?
|
| Fertility | 1 | 2022 | 260 | 0.620 |
Why?
|
| Pregnancy | 18 | 2025 | 7512 | 0.570 |
Why?
|
| Maternal Exposure | 2 | 2016 | 150 | 0.520 |
Why?
|
| Energy Metabolism | 1 | 2020 | 804 | 0.460 |
Why?
|
| Mice | 16 | 2025 | 18301 | 0.430 |
Why?
|
| Vascular Diseases | 1 | 2016 | 146 | 0.420 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4697 | 0.420 |
Why?
|
| Animals | 19 | 2026 | 33912 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 4738 | 0.380 |
Why?
|
| Food Deprivation | 1 | 2012 | 33 | 0.370 |
Why?
|
| Deoxyguanosine | 1 | 2011 | 11 | 0.340 |
Why?
|
| Embryo Implantation | 2 | 2024 | 218 | 0.340 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 23 | 0.340 |
Why?
|
| Adrenomedullin | 3 | 2022 | 83 | 0.330 |
Why?
|
| Obesity | 3 | 2025 | 2426 | 0.320 |
Why?
|
| Pre-Eclampsia | 2 | 2020 | 226 | 0.320 |
Why?
|
| Antioxidants | 1 | 2011 | 331 | 0.290 |
Why?
|
| Insulin | 4 | 2022 | 1149 | 0.270 |
Why?
|
| Female | 20 | 2025 | 70963 | 0.250 |
Why?
|
| Oxidative Stress | 1 | 2011 | 791 | 0.240 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3819 | 0.240 |
Why?
|
| Menstrual Cycle | 1 | 2026 | 33 | 0.230 |
Why?
|
| Pregnancy Complications | 2 | 2025 | 567 | 0.230 |
Why?
|
| Mitochondria, Liver | 1 | 2025 | 37 | 0.220 |
Why?
|
| Liver | 3 | 2025 | 1796 | 0.220 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2024 | 27 | 0.210 |
Why?
|
| Fallopian Tubes | 1 | 2024 | 66 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 2 | 2020 | 61 | 0.200 |
Why?
|
| Postpartum Period | 1 | 2025 | 245 | 0.190 |
Why?
|
| Fatty Liver | 1 | 2025 | 224 | 0.190 |
Why?
|
| Progesterone | 1 | 2024 | 439 | 0.180 |
Why?
|
| Parturition | 1 | 2022 | 65 | 0.180 |
Why?
|
| Glucose | 2 | 2022 | 853 | 0.170 |
Why?
|
| Streptococcal Infections | 1 | 2024 | 254 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 1 | 2022 | 133 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 757 | 0.160 |
Why?
|
| Receptors, Complement 3b | 1 | 2020 | 13 | 0.160 |
Why?
|
| Lipolysis | 1 | 2020 | 83 | 0.160 |
Why?
|
| Placentation | 1 | 2020 | 59 | 0.160 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2326 | 0.140 |
Why?
|
| Microbiota | 1 | 2024 | 438 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 137 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 484 | 0.130 |
Why?
|
| Spermatogenesis | 1 | 2018 | 166 | 0.130 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 66 | 0.120 |
Why?
|
| Animal Feed | 1 | 2017 | 82 | 0.120 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2017 | 48 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 80 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 710 | 0.120 |
Why?
|
| Testis | 1 | 2018 | 389 | 0.120 |
Why?
|
| Acetylcholine | 1 | 2016 | 69 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2016 | 182 | 0.110 |
Why?
|
| Caloric Restriction | 1 | 2015 | 107 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2020 | 1345 | 0.110 |
Why?
|
| Fibrosis | 1 | 2016 | 429 | 0.100 |
Why?
|
| Hair Color | 1 | 2012 | 12 | 0.100 |
Why?
|
| Genistein | 1 | 2012 | 40 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1939 | 0.090 |
Why?
|
| Motor Activity | 1 | 2015 | 489 | 0.090 |
Why?
|
| Phenols | 1 | 2012 | 73 | 0.090 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 55 | 0.090 |
Why?
|
| Sex Factors | 1 | 2016 | 1356 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 79 | 0.090 |
Why?
|
| Apoptosis | 1 | 2018 | 1827 | 0.090 |
Why?
|
| Body Weight | 1 | 2015 | 987 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2020 | 2406 | 0.080 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2016 | 402 | 0.080 |
Why?
|
| Humans | 7 | 2026 | 131163 | 0.080 |
Why?
|
| Transcriptome | 1 | 2015 | 1103 | 0.070 |
Why?
|
| Gene Expression | 2 | 2020 | 1481 | 0.050 |
Why?
|
| Streptococcus | 1 | 2024 | 64 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2024 | 106 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2022 | 16 | 0.050 |
Why?
|
| Vagina | 1 | 2024 | 208 | 0.040 |
Why?
|
| Autophagy | 1 | 2025 | 417 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2024 | 262 | 0.040 |
Why?
|
| Complement Inactivating Agents | 1 | 2020 | 14 | 0.040 |
Why?
|
| Complement C3 | 1 | 2020 | 44 | 0.040 |
Why?
|
| Receptors, Complement | 1 | 2020 | 34 | 0.040 |
Why?
|
| Complement Activation | 1 | 2020 | 50 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2323 | 0.040 |
Why?
|
| Male | 5 | 2018 | 64957 | 0.040 |
Why?
|
| Trophoblasts | 1 | 2020 | 113 | 0.040 |
Why?
|
| Perilipin-1 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2019 | 9 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 197 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2019 | 23 | 0.040 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2019 | 21 | 0.040 |
Why?
|
| Dietary Sugars | 1 | 2019 | 19 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 65 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 149 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 664 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 373 | 0.030 |
Why?
|
| Binding Sites | 1 | 2020 | 1133 | 0.030 |
Why?
|
| Sperm Count | 1 | 2018 | 100 | 0.030 |
Why?
|
| Cytokines | 1 | 2024 | 1339 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 523 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 588 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3385 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2019 | 687 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2015 | 54 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 52 | 0.030 |
Why?
|
| Pancreas | 1 | 2016 | 217 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1021 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 1459 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 143 | 0.020 |
Why?
|
| Triglycerides | 1 | 2016 | 602 | 0.020 |
Why?
|
| Eating | 1 | 2015 | 377 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1205 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 152 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 470 | 0.020 |
Why?
|
| Mutation | 2 | 2016 | 6099 | 0.020 |
Why?
|
| Gestational Age | 1 | 2015 | 1224 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 688 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 11074 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1447 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 6196 | 0.010 |
Why?
|